After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported no evidence of disease (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization.
Very encouraging and very similar to what we found over a longer time period. Makis, W., Baghli, I., & Martinez, P. (2025). Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients. Case reports in oncology, 18(1), 856–863. https://doi.org/10.1159/000546362.
“….a fundamental question: how many clinically meaningful signals have been overlooked, deprioritized, or never pursued because they fall outside the conventional commercial drug development model?”
Please collaborate, to get a larger study population, with oncologist William Maxis, who now resides in Florida,. He has helped thousands of cancer patients by recommending Ivermectin and Fenbendazole during the last couple of years.
If it is possible to prove Big Pharma was actively suppressing these treatments to protect their chemotherapy profits, that sounds like criminal negligence causing death on an industrial scale.
The evidence of that, indirectly, was when they went bonkers over Ivermectin during COVID. Yes, they were protecting the "need for the vaccine", but they undoubtably knew the benefits in cancer, and were petrified they were going to be brought to light, unless it remained a "horse paste".
KUDOS to all of the Collaborators and especially to some of my COURAGEOUS, SACRIFICIAL, COMPASSIONATE, BRILLIANT FAVES: Nicolas Hulscher, Dr. McCullough, Dr. Thorp and Dr. Risch.
Thoughts of the horrible disease of cancer have haunted me for three decades after witnessing my Mom endure chemotherapy, radiation therapy and then try to heal/recover from a "morbid" surgery in efforts to save her life. Her oncologist called her a "stoic" woman and did his best but she endured all of that for 6 years then died after it recurred.
This EXCELLENT analysis gives me hope for "low-toxicity therapeutic approaches" in the future.
It would be very interesting to see a long term comparison of this treatment protocol vs classic oncologic therapy, particularly in adherence and tumor recurrence/metastases. Is the 38% dropout/LTF rate similar to classic treatment?
Very encouraging and very similar to what we found over a longer time period. Makis, W., Baghli, I., & Martinez, P. (2025). Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients. Case reports in oncology, 18(1), 856–863. https://doi.org/10.1159/000546362.
I've been able to download these studies…but retracted is stamped over each one
Does this surprise you?
“….a fundamental question: how many clinically meaningful signals have been overlooked, deprioritized, or never pursued because they fall outside the conventional commercial drug development model?”
Tragically, far too many. 😢
Yet another crime against humanity.
Please collaborate, to get a larger study population, with oncologist William Maxis, who now resides in Florida,. He has helped thousands of cancer patients by recommending Ivermectin and Fenbendazole during the last couple of years.
Makis, not Maxis.
Any plans to add a group that also includes fasting and/or ketogenic diet?
This is great news.
If it is possible to prove Big Pharma was actively suppressing these treatments to protect their chemotherapy profits, that sounds like criminal negligence causing death on an industrial scale.
The evidence of that, indirectly, was when they went bonkers over Ivermectin during COVID. Yes, they were protecting the "need for the vaccine", but they undoubtably knew the benefits in cancer, and were petrified they were going to be brought to light, unless it remained a "horse paste".
Wouldn't it be advantageous to publish your study in the IMA's Journal of Independent Medicine?
🙌
Great news.
KUDOS to all of the Collaborators and especially to some of my COURAGEOUS, SACRIFICIAL, COMPASSIONATE, BRILLIANT FAVES: Nicolas Hulscher, Dr. McCullough, Dr. Thorp and Dr. Risch.
Thoughts of the horrible disease of cancer have haunted me for three decades after witnessing my Mom endure chemotherapy, radiation therapy and then try to heal/recover from a "morbid" surgery in efforts to save her life. Her oncologist called her a "stoic" woman and did his best but she endured all of that for 6 years then died after it recurred.
This EXCELLENT analysis gives me hope for "low-toxicity therapeutic approaches" in the future.
It would be very interesting to see a long term comparison of this treatment protocol vs classic oncologic therapy, particularly in adherence and tumor recurrence/metastases. Is the 38% dropout/LTF rate similar to classic treatment?